{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:33:57Z","timestamp":1780508037193,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,22]]},"DOI":"10.7759\/cureus.22505","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:33:56Z","timestamp":1645576436000},"source":"Crossref","is-referenced-by-count":5,"title":["Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Satoshi","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Misugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07717.x","article-title":"Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production","volume":"146","author":"Nugent D","year":"2009","unstructured":"Nugent D, McMillan R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and\/or decreased platelet production. Br J Haematol. 2009, 146:585-96. 10.1111\/j.1365-2141.2009.07717.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14697","article-title":"Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study","volume":"125","author":"Care A","year":"2018","unstructured":"Care A, Pavord S, Knight M, Alfirevic Z. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG. 2018, 125:604-12. 10.1111\/1471-0528.14697","journal-title":"BJOG"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12120","article-title":"Outcomes of pregnancy following postpartum haemorrhage","volume":"120","author":"Fullerton G","year":"2013","unstructured":"Fullerton G, Danielian PJ, Bhattacharya S. Outcomes of pregnancy following postpartum haemorrhage. BJOG. 2013, 120:621-7. 10.1111\/1471-0528.12120","journal-title":"BJOG"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1014202","article-title":"Thrombopoietin-receptor agonists for primary immune thrombocytopenia","volume":"365","author":"Imbach P","year":"2011","unstructured":"Imbach P, Crowther M. Thrombopoietin-receptor agonists for primary immune thrombocytopenia. N Engl J Med. 2011, 365:734-41. 10.1056\/NEJMct1014202","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2009.06.011","article-title":"Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function","volume":"37","author":"Erhardt JA","year":"2009","unstructured":"Erhardt JA, Erickson-Miller CL, Aivado M, Abboud M, Pillarisetti K, Toomey JR. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function. Exp Hematol. 2009, 37:1030-7. 10.1016\/j.exphem.2009.06.011","journal-title":"Exp Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60959-2","article-title":"Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study","volume":"377","author":"Cheng G","year":"2011","unstructured":"Cheng G, Saleh MN, Marcher C, et al.. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet. 2011, 377:393-402. 10.1016\/S0140-6736(10)60959-2","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00279-8","article-title":"Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"Tarantino MD","year":"2016","unstructured":"Tarantino MD, Bussel JB, Blanchette VS, et al.. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016, 388:45-54. 10.1016\/S0140-6736(16)00279-8","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61107-2","article-title":"Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial","volume":"386","author":"Grainger JD","year":"2015","unstructured":"Grainger JD, Locatelli F, Chotsampancharoen T, et al.. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015, 386:1649-58. 10.1016\/S0140-6736(15)61107-2","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel JB","year":"2007","unstructured":"Bussel JB, Cheng G, Saleh MN, et al.. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med. 2007, 357:2237-47. 10.1056\/NEJMoa073275","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616663849","article-title":"Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials","volume":"23","author":"Elgebaly AS","year":"2017","unstructured":"Elgebaly AS, Ashal GE, Elfil M, Menshawy A. Tolerability and efficacy of eltrombopag in chronic immune thrombocytopenia: meta-analysis of randomized controlled trials. Clin Appl Thromb Hemost. 2017, 23:928-37. 10.1177\/1076029616663849","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9920","article-title":"Romiplostim and eltrombopag in immune thrombocytopenia as a second-line treatment","volume":"12","author":"Bidika E","year":"2020","unstructured":"Bidika E, Fayyaz H, Salib M, Memon AN, Gowda AS, Rallabhandi B, Cancarevic I. Romiplostim and eltrombopag in immune thrombocytopenia as a second-line treatment. Cureus. 2020, 12:e9920. 10.7759\/cureus.9920","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13266","article-title":"Use of eltrombopag after romiplostim in primary immune thrombocytopenia","volume":"169","author":"Gonz\u00e1lez-Porras JR","year":"2015","unstructured":"Gonz\u00e1lez-Porras JR, Mingot-Castellano ME, Andrade MM, et al.. Use of eltrombopag after romiplostim in primary immune thrombocytopenia. Br J Haematol. 2015, 169:111-6. 10.1111\/bjh.13266","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1640870","article-title":"Managing ITP and thrombocytopenia in pregnancy","volume":"31","author":"Eslick R","year":"2020","unstructured":"Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets. 2020, 31:300-6. 10.1080\/09537104.2019.1640870","journal-title":"Platelets"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312463621","article-title":"Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus","volume":"21","author":"Alkaabi JK","year":"2012","unstructured":"Alkaabi JK, Alkindi S, Riyami NA, Zia F, Balla LM, Balla SM. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus. Lupus. 2012, 21:1571-4. 10.1177\/0961203312463621","journal-title":"Lupus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000621","article-title":"Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report","volume":"10","author":"Favier R","year":"2018","unstructured":"Favier R, De Carne C, Elefant E, Lapusneanu R, Gkalea V, Rigouzzo A. Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report. A A Pract. 2018, 10:10-2. 10.1213\/XAA.0000000000000621","journal-title":"A A Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.177204","article-title":"A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag","volume":"10","author":"Purushothaman J","year":"2016","unstructured":"Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S. A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. Asian J Transfus Sci. 2016, 10:155-8. 10.4103\/0973-6247.177204","journal-title":"Asian J Transfus Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2018.06.010","article-title":"Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - A case report","volume":"47","author":"Ferreira IJ","year":"2018","unstructured":"Ferreira IJ, Sousa F, Vasco EM, Areia AL, Moura JP, Carda J, Ribeiro L. Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - A case report. J Gynecol Obstet Hum Reprod. 2018, 47:405-8. 10.1016\/j.jogoh.2018.06.010","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2383-1","article-title":"A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag","volume":"108","author":"Suzuki N","year":"2018","unstructured":"Suzuki N, Hiraga J, Hariyama Y, et al.. A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag. Int J Hematol. 2018, 108:109-11. 10.1007\/s12185-017-2383-1","journal-title":"Int J Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan D","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al.. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019, 3:3780-817. 10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.144","article-title":"Thrombocytopenia in pregnancy","volume":"2017","author":"Cines DB","year":"2017","unstructured":"Cines DB, Levine LD. Thrombocytopenia in pregnancy. Hematol Am Soc Hematol Educ Program. 2017, 2017:144-51. 10.1182\/asheducation-2017.1.144","journal-title":"Hematol Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85448-use-of-eltrombopag-for-the-first-trimester-pregnancy-complicated-with-refractory-idiopathic-thrombocytopenic-purpura-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:37Z","timestamp":1707507937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85448-use-of-eltrombopag-for-the-first-trimester-pregnancy-complicated-with-refractory-idiopathic-thrombocytopenic-purpura-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22505","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,22]]}}}